Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

News · June 03, 2019

ASCO 2019: FOxTROT Trial Suggests Neoadjuvant Approach Improves Outcomes in Colon Cancer

But the failure to reach statistical significance calls into question whether this approach should be adopted as the gold standard

PracticeUpdate Editorial Team

 

Further Reading